Registries for Evaluating Patient Outcomes - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Registries for Evaluating Patient Outcomes write by Agency for Healthcare Research and Quality/AHRQ. This book was released on 2014-04-01. Registries for Evaluating Patient Outcomes available in PDF, EPUB and Kindle. This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.
Monitoring for Drug Safety
Monitoring for Drug Safety - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Monitoring for Drug Safety write by William Howard Wallace Inman. This book was released on 1980. Monitoring for Drug Safety available in PDF, EPUB and Kindle.
Practical Drug Safety from A to Z
Practical Drug Safety from A to Z - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Practical Drug Safety from A to Z write by Barton Cobert. This book was released on 2009-10-06. Practical Drug Safety from A to Z available in PDF, EPUB and Kindle. The Practical Drug Safety from A to Z is an alphabetical guide to drug safety monitoring (pharmacovigilance), covering literally, the "A to Z" of maintaining drug safety. Written by experts in the field, this book is a perfect to companion to the Manual of Drug Safety and Pharmacovigilance and an essential reference for pharmacists, pharmacologists, hospital administrators, medical liability lawyers, and others.
Drug Safety in Developing Countries
Drug Safety in Developing Countries - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Drug Safety in Developing Countries write by Yaser Mohammed Al-Worafi. This book was released on 2020-06-03. Drug Safety in Developing Countries available in PDF, EPUB and Kindle. Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. - Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues - Describes current achievements of drug safety practice in developing countries - Addresses the challenges of drug safety in developing countries - Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety
Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis
Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis write by World Health Organization. This book was released on 2015-04-20. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis available in PDF, EPUB and Kindle. This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly's resolution on prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Resolution WHA62.15, adopted in 2009, calls on Member States to develop a comprehensive framework for the management and care of patients with drug-resistant TB. The recommendations contained in these guidelines address the most topical questions concerning the programmatic management of drug-resistant TB: case-finding, multidrug resistance, treatment regimens, monitoring the response to treatment, and selecting models of care. The guidelines primarily target staff and medical practitioners working in TB treatment and control, and partners and organizations providing technical and financial support for care of drug-resistant TB in settings where resources are limited.
